Hospital de la Santa Creu i Sant Pau-ko ikertzaileekin lankidetzan egindako argitalpenak (23)

2024

  1. Epidemiological and Clinical Insights into the Enterovirus D68 Upsurge in Europe 2021-2022 and Emergence of Novel B3-Derived Lineages, ENPEN Multicentre Study

    Journal of Infectious Diseases, Vol. 230, Núm. 4, pp. e917-e928

2022

  1. Effectiveness of Fosfomycin for the Treatment of Multidrug-Resistant Escherichia coli Bacteremic Urinary Tract Infections: A Randomized Clinical Trial

    JAMA Network Open, Vol. 5, Núm. 1

2021

  1. Acute flaccid paralysis and enterovirus in Spain. Results from 2019 surveillance

    Vacunas, Vol. 22, Núm. 1, pp. 28-38

  2. Spread of a SARS-CoV-2 variant through Europe in the summer of 2020

    Nature, Vol. 595, Núm. 7869, pp. 707-712

  3. The first wave of the COVID-19 epidemic in Spain was associated with early introductions and fast spread of a dominating genetic variant

    Nature Genetics, Vol. 53, Núm. 10, pp. 1405-1414

2019

  1. Enterovirus D68-associated respiratory and neurological illness in Spain, 2014–2018

    Emerging Microbes and Infections, Vol. 8, Núm. 1, pp. 1438-1444

  2. Molecular epidemiology of an enterovirus A71 outbreak associated with severe neurological disease, Spain, 2016

    Eurosurveillance, Vol. 24, Núm. 7

2018

  1. Epidemiological and clinical characteristics of infants admitted to hospital due to human parechovirus infections: A prospective study in Spain

    Anales de Pediatria, Vol. 88, Núm. 2, pp. 82-88

2017

  1. Importancia de los enterovirus en neuropediatría: De los poliovirus a otros enterovirus

    Revista de Neurologia, Vol. 64, pp. S35-S38

  2. Molecular epidemiology of enterovirus and parechovirus infections according to patient age over a 4-year period in Spain

    Journal of Medical Virology, Vol. 89, Núm. 3, pp. 435-442

  3. The carbapenemase-producing Klebsiella pneumoniae population is distinct and more clonal than the carbapenem-susceptible population

    Antimicrobial Agents and Chemotherapy, Vol. 61, Núm. 4

2016

  1. Molecular epidemiology of coxsackievirus B3 infection in Spain, 2004-2014

    Archives of Virology, Vol. 161, Núm. 5, pp. 1365-1370

2015

  1. Comparison of epidemiology and clinical characteristics of infections by human parechovirus vs. those by enterovirus during the first month of life

    European Journal of Pediatrics, Vol. 174, Núm. 11, pp. 1511-1516

  2. Multicenter Study of Epidemiological Cutoff Values and Detection of Resistance in Candida spp. to Anidulafungin, Caspofungin, and Micafungin Using the Sensititre YeastOne Colorimetric Method

    Antimicrobial Agents and Chemotherapy, Vol. 59, Núm. 11, pp. 6725-6732

2014

  1. Design and validation of a real-time RT-PCR for the simultaneous detection of enteroviruses and parechoviruses in clinical samples

    Journal of Virological Methods, Vol. 208, pp. 125-128

2012

  1. Comparison of three statistical methods for establishing tentative wild-type population and epidemiological cutoff values for echinocandins, amphotericin B, flucytosine, and six Candida species as determined by the colorimetric sensititre yeastone method

    Journal of Clinical Microbiology, Vol. 50, Núm. 12, pp. 3921-3926

  2. Epidemiology, species distribution and in vitro antifungal susceptibility of fungaemia in a Spanish multicentre prospective survey

    Journal of Antimicrobial Chemotherapy, Vol. 67, Núm. 5, pp. 1181-1187

2011

  1. Prospective multicenter study of the epidemiology, molecular identification, and antifungal susceptibility of Candida parapsilosis, Candida orthopsilosis, and Candida metapsilosis isolated from patients with candidemia

    Antimicrobial Agents and Chemotherapy, Vol. 55, Núm. 12, pp. 5590-5596

2008

  1. Didanosine, lamivudine, and efavirenz versus zidovudine, lamivudine, and efavirenz for the initial treatment of hiv type 1 infection: Final analysis (48 weeks) of a prospective, randomized, noninferiority clinical trial, GESIDA 3903

    Clinical Infectious Diseases, Vol. 47, Núm. 8, pp. 1083-1092

  2. Staphylococcus spp. en España: Situación actual y evolución de la resistencia a antimicrobianos (1986-2006)

    Enfermedades Infecciosas y Microbiologia Clinica, Vol. 26, Núm. 5, pp. 269-277